OTCPK:HTLZF - Post by User
Post by
Betteryear2on Jul 22, 2024 7:15pm
180 Views
Post# 36143483
Hamilton Thorne Announces Agreement to be Acquired
Hamilton Thorne Announces Agreement to be Acquired - Purchase price of CAD$2.25 per Hamilton Thorne share represents enterprise value of approximately CAD$388 million (US$282 million).
- Represents a premium of approximately 54% to the closing price on the Toronto Stock Exchange (“TSX”) of Hamilton Thorne shares on July 19, 2024, the last trading day prior to the announcement of the transaction, and approximately 62% to the 90-day VWAP as of the same date1.
- The Board of Directors of Hamilton Thorne (with interested directors abstaining) unanimously determined that the transaction is in the best interests of Hamilton Thorne and the transaction consideration to be received by the Hamilton Thorne shareholders is fair, from a financial point of view.
BEVERLY, Mass. and TORONTO, July 22, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd (TSX: HTL) (“Hamilton Thorne” or the “Company”), a leading provider of precision instruments, consumables, software, and services to the Assisted Reproductive Technologies (“ART”), research, and the cell biology space, today announced that it has entered into a definitive arrangement agreement dated July 21, 2024 (the “Arrangement Agreement”) with an acquisition vehicle (the “Purchaser”) managed by Astorg, a leading private equity firm with an extensive track record in global healthcare investments, whereby the Purchaser has agreed to acquire 100% of the issued and outstanding common shares (the “Company Shares”) of the Company (the “Transaction”).
Hamilton Thorne Announces Agreement to be Acquired by (globenewswire.com)